2023
DOI: 10.25156/ptj.v12n2y2022.pp53-60
|View full text |Cite
|
Sign up to set email alerts
|

The Impact of Dapagliflozin on Aldosterone Hormone in Rats with Heart Failure

Abstract: Background: The latest anti-diabetic medication sodium-glucose co-transporter inhibitor along with the lowering of blood glucose has a cardioprotective and reno-protective effect, it has the ability to reduce the development of heart failure and decrease hospitalization in heart failure subjects with and without diabetes. This study was conducted to evaluate the effect of sodium-glucose co-transporter inhibitor dapagliflozin alone and in combination with eplerenone on the aldosterone hormone in the treatment o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 23 publications
(25 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?